<?xml version="1.0" encoding="ISO-8859-1"?>

<?xml-stylesheet type="text/css" href="https://www.webwire.com/includes/rssstyle.css"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
  
  <!-- Issuers of news/press releases and NOT WebWire are solely responsible for the accuracy of the content. -->



    <title>WebWire | News by Industry : Biotechnology</title>
    <link>https://www.webwire.com/</link>
    <description>Biotechnology News by WebWire</description>
    <language>en-US</language>
    <copyright>Copyright &#169; 2026 WebWire. All Rights Reserved.</copyright>
    <ttl>15</ttl>
    <lastBuildDate>Sat, 10 Oct 2026 16:50:50 EDT</lastBuildDate>
	<image>
      <title>WebWire | News by Industry : Biotechnology</title>
      <width>140</width>
      <height>32</height>
      <link>https://www.webwire.com/</link>
      <url>https://www.webwire.com/imgs/webwire_logo_140x32.gif</url>
    </image>
	

  <item>
     <title>&#8220;Understanding AFib: Think Clearly About AFib, Make Confident Treatment Decisions&#8221; - Best-Selling Book Offered for Free (Ending Soon) (Until 10/09/26)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=361311</link>
     <pubDate>Wed, 7 Oct 2026 06:00:00 EDT</pubDate>
     <description><![CDATA[<p> Best Seller Publishing announces the release of Scott Lee&#39;s new book,   &#8220;Understanding AFib: Think Clearly About AFib, Make Confident Treatment Decisions.&#8221;   It will be available in the Amazon store for free for two more days. -   -   &#8220;Understanding AFib&#8221;  is about helping patients make sense of atrial fibrillation and the different treatment options their doctors may recommend. When physicians suggest medication, ablation, or simply monitoring, patients may struggle to understand why approach...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=361311">https://www.webwire.com/ViewPressRel.asp?aId=361311</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/40662/361311/361311-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID361311</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Mitsui Chemicals Launches InnoCell&#8482; P-Type High Oxygen-Permeable Culture Plates to Accelerate Organoid-Based Drug Discovery</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=361477</link>
     <pubDate>Tue, 6 Oct 2026 10:17:26 EDT</pubDate>
     <description><![CDATA[<p> Mitsui Chemicals, Inc. (Tokyo; President &amp; CEO: Satoshi Ichimura) has launched InnoCell&#8482; P-Type, a new adherent cell culture plate in its InnoCell&#8482; series of cell culture ware, as of October 1, 2026. -   -  InnoCell&#8482; P-Type combines Mitsui Chemicals&#39; proprietary highly oxygen-permeable material technology with original surface treatment technology. By providing an environment that helps cells maintain functions closer to those observed in vivo, the plate supports the development of organoids a...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=361477">https://www.webwire.com/ViewPressRel.asp?aId=361477</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/361477/361477-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID361477</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>ConV2X Unveils NYC Executive Summit Agenda on Emerging Tech &#8211; What it Delivers and What Leaders Must Do Next</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=361351</link>
     <pubDate>Tue, 6 Oct 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Partners in Digital Health will convene the  ConV2X Smart Tech Transformation in Healthcare &amp; Life Sciences Executive Summit  on October 29-30, 2026, at the ILR Conference Center in the historic GE Building, 570 Lexington Avenue, New York City. -   -  Guided by the premise  &#8220;Healthcare&#39;s Challenges Can&#39;t Be Solved in Silos,&#8221;  the 2 Day summit brings leaders across disciplines together to examine the decisions shaping healthcare and life sciences: where emerging technologies improve outcomes, w...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=361351">https://www.webwire.com/ViewPressRel.asp?aId=361351</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/361351/361351-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID361351</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Powered by muscle cells, a paper-thin robot swims through watery maze</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=361111</link>
     <pubDate>Tue, 29 Sep 2026 08:08:41 EDT</pubDate>
     <description><![CDATA[<p> Swimming can take a lot of muscle. But as MIT engineers have found, even a single layer of muscle cells can power through water if designed right.  -   -  In a paper appearing today in the journal  Advanced Functional Materials, the team presents a design for a thin, muscle-powered swimming robot. The &#8220;skeleton&#8221; of the aquabot is made from a film of gel that is about the length and width of a stick of gum. The two halves of the gel form the &#8220;fins&#8221; of the bot. Each fin is covered with a layer o...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=361111">https://www.webwire.com/ViewPressRel.asp?aId=361111</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/361111/361111-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID361111</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>OneSkin Introduces a New Approach to Rich Creams, Designed for Skin Longevity</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=360792</link>
     <pubDate>Tue, 22 Sep 2026 07:00:00 EDT</pubDate>
     <description><![CDATA[<p>   OneSkin, the skin longevity company behind the first peptide proven to reverse skin&#39;s biological age, today launched  OS-01 FACE RICH CREAM, a first-of-its-kind formula engineered to address the biological changes that drive age-related moisture loss. Powered by OneSkin&#39;s proprietary  OS-01 Peptide&#8482;  and a Dual-Phase Hydration System, OS-01 FACE RICH CREAM works at the structural level, restoring skin&#39;s firmness, resilience and capacity to hold onto hydration long-term. -   -  &#8220;Rich creams...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=360792">https://www.webwire.com/ViewPressRel.asp?aId=360792</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/108079/360792/360792-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID360792</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Telehealth and Medicine Today Announces 2025 Research Article Award Recipients</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=360731</link>
     <pubDate>Mon, 21 Sep 2026 08:30:00 EDT</pubDate>
     <description><![CDATA[<p>  Telehealth and Medicine Today  (THMT), an international peer reviewed journal advancing telehealth, digital health and medical innovation, today announced the recipients of its 2025 research article honors. The annual recognitions are based on a combined assessment of article views, downloads, citations and the significance and impact of each topic on healthcare and industry. -   -  The  2025 THMT Editors&#39; Best Research Article Award  is presented to: -   &#8220;The Impact of Digital Health Technolog...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=360731">https://www.webwire.com/ViewPressRel.asp?aId=360731</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/360731/360731-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID360731</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>New Medicare and Medicaid GLP-1 Programs Spotlight Lifestyle Support as Menu-Order AI Launches Daily GLP-1 Habit Tracker, Helping Users Stay on Track</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=360479</link>
     <pubDate>Mon, 14 Sep 2026 19:39:41 EDT</pubDate>
     <description><![CDATA[<p>  Menu-Order AI  today announced Daily GLP-1 Habits, a new feature created in conjunction with Founding Medical Advisor Dr. Leigh-Anne Dale. The addition extends Menu-Order AI from restaurant decisions into daily tracking &#8212; helping users choose what to order, log meals and macros, monitor steps and document their daily habits. -   -  The launch comes as federal coverage of GLP-1 medications widens alongside a push for lifestyle support. The Centers for Medicare &amp; Medicaid Services began its Med...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=360479">https://www.webwire.com/ViewPressRel.asp?aId=360479</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/102404/360479/360479-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID360479</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>BHTY Announces Recipients of the 2025 Editors Best Article Awards</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=360421</link>
     <pubDate>Mon, 14 Sep 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Blockchain in Healthcare Today Platform Approaches Journal (BHTY) has announced the recipients of its 2025 Editors Best Article Awards, recognizing two outstanding contributions to the scholarly record and the advancement of emerging technology across healthcare and life sciences. -   -  The annual awards recognize one original research article and one editorial article. Recipients are selected based on article views and downloads, contribution to the scholarly record, and the Editor-in-Chief&#39;...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=360421">https://www.webwire.com/ViewPressRel.asp?aId=360421</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/360421/360421-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID360421</guid>
     <dc:type>Article</dc:type>
  </item>

  </channel>
</rss>
